查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2003960

乳膠醫用手套市場：2026-2032年全球市場預測（依產品塗層、應用、最終用戶和銷售管道分類）

Latex Medical Gloves Market by Product Coating, Application Type, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年乳膠醫用手套市值為141.3億美元，預計到2026年將成長至149.3億美元，複合年成長率為5.24%，到2032年將達到202.2億美元。

主要市場統計數據
基準年 2025 141.3億美元
預計年份：2026年 149.3億美元
預測年份 2032 202.2億美元
複合年成長率 (%) 5.24%

對乳膠醫用手套品類的深入介紹，清楚地平衡了臨床性能優先事項與供應鏈和監管現實。

乳膠醫用手套在臨床表現、供應鏈複雜性和不斷變化的監管要求之間處於關鍵的交匯點。本報告首先將乳膠手套置於臨床對觸覺靈敏度和貼合度的需求背景下進行分析，同時對比分析了乳膠蛋白致敏性日益成長的擔憂以及整個行業向替代彈性體轉變的趨勢。報告首先闡明了產品範圍，包括無粉和有粉產品，並區分了優先考慮靈巧性、阻隔功能或長時間佩戴的應用場景。

臨床安全問題、永續性要求和不斷變化的分銷管道如何相互交織，從根本上改變乳膠手套產業的格局。

乳膠醫用手套產業正經歷一場變革，其驅動力包括安全通訊協定的完善、材料科學的進步以及醫療採購結構的變化。在臨床環境中，人們對乳膠過敏的認知不斷提高，加速了許多醫療機構採用替代材料，迫使製造商改進配方並調整生產策略。同時，永續性要求正在重塑產品設計和包裝決策，而生命週期考量也影響採購選擇，因為醫院和醫療系統都在努力減少醫療廢棄物並提高環境資訊揭露水平。

分析研究計畫於 2025 年實施的美國關稅變化將如何累積改變整個乳膠手套價值鏈的成本結構、籌資策略和供應彈性。

美國宣布的2025年關稅調整可能對乳膠醫用手套的採購、定價和庫存策略產生累積壓力。關稅對進口醫療用品最直接的影響是增加依賴進口的買家的收貨成本。因此，採購團隊將被迫重新評估其供應商組合，並將採購量轉向國內生產或其他替代來源。從長遠來看，這些成本訊號將促使企業做出結構性調整。供應商可能會重組製造地、投資本地或區域生產，或重新談判貿易條款以維持市場進入。

將產品塗層、應用、終端用戶趨勢和分銷管道與臨床要求和採購行為聯繫起來的詳細細分洞察。

細分市場分析揭示了微妙的需求模式，這些模式應指南整個乳膠手套品類的產品開發和商業策略。根據產品塗層，臨床醫生和採購負責人會根據易用性、顆粒控制和監管認可的差異來區分無粉手套和有粉手套。在污染控制和患者安全至關重要的環境中，無粉產品越來越受歡迎，而有粉產品在需要快速佩戴的特定應用領域仍然效用。依應用領域分類，市場分為檢查手套和外科手套，外科手套又進一步細分為心血管外科、一般外科和整形外科。每個領域對觸感、拉伸強度和無菌性都有其獨特的要求，指南材料的選擇和品質檢驗。

美洲、歐洲、中東和非洲以及亞太地區的區域法規結構、製造地和採購重點如何影響產品採用和供應彈性？

區域趨勢影響整個乳膠手套品類的供應能力和需求偏好，美洲、歐洲、中東、非洲和亞太地區之間存在顯著差異。在美洲，臨床採購負責人除了重視物流可靠性外，還優先考慮合規性和供應商透明度。此外，本地生產能力和近岸外包方案也越來越受到重視，以降低進口中斷和關稅波動帶來的風險。從臨床需求角度來看，北美和南美的醫療機構通常優先考慮兼具良好觸感和成熟品管系統的產品。

製造商、經銷商和策略夥伴如何透過品質系統、供應合約和附加價值服務來脫穎而出，從而與機構建立長期合作關係？

乳膠手套產業的競爭格局正因能力差異化、品質保證投入和策略夥伴關係而重塑。領先的製造商正投資於製程控制、過敏原減少技術和第三方認證，以維繫與醫院和手術室的合作關係。同時，新參與企業則專注於生物分解材料、客製化無菌包裝和快速反應生產線等細分價值提案，以支持緊急採購。分銷合作夥伴和醫療批發商正在其服務組合中增加庫存分析、合約管理支援和電子採購整合等服務，從而提升了數位化管道和數據驅動型客戶參與的重要性。

製造商和經銷商現在可以實施的可操作策略行動，以增強韌性、滿足臨床需求並實現永續的商業性差異化。

產業領導企業可以透過調整產品系列、供應鏈和經營模式，使其與不斷變化的臨床和監管要求相適應，從而採取果斷措施來鞏固其市場地位。首先，製造商應優先投資於減少過敏原的製程、完善的品管系統以及符合醫院採購要求的可驗證檢驗，從而減少供應商認證過程中的阻力。其次，企業應實現製造地多元化，並確保關鍵供應地點的冗餘，以避免關稅風險和物流中斷的影響，同時也能快速回應區域性需求激增。

為了檢驗可操作的產業見解，調查方法，結合了對臨床負責人的訪談、供應鏈映射和情境分析。

本報告的調查方法結合了定性和定量方法，旨在全面了解乳膠醫用手套對環境的影響。首先，我們對臨床採購經理、感染控制專家、分銷主管和監管顧問進行了訪談，以了解他們對產品性能、採購限制和認證障礙的第一手觀點。其次，我們利用監管指導文件、生產最佳實踐框架和公開的公司報告進行二次研究，全面檢驗了有關生產方法、品質系統和分銷模式的說法。

綜合結論強調，品質、供應彈性和永續性是決定乳膠手套長期競爭優勢的必要條件。

總而言之，乳膠醫用手套正處於策略轉折點，臨床安全考量、供應鏈韌性和永續性需求在此交匯融合。儘管乳膠在許多臨床應用中，尤其是在靈敏度和貼合度至關重要的外科手術中，仍然具有明顯的觸感優勢，但過敏問題和替代彈性體的興起正在重塑採購決策和創新重點。同時，隨著買家要求更高的透明度、更快的補貨速度和更柔軟性的合約條款以規避成本和供應波動風險，分銷管道和合約機制也在不斷演變。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：乳膠醫用手套市場（依產品塗層分類）

  • 無粉
  • 粉末

第9章：按應用分類的乳膠醫用手套市場

  • 諮詢
  • 外科手術
    • 心血管外科
    • 一般外科
    • 整形外科手術

第10章：乳膠醫用手套市場：依最終用戶分類

  • 門診部
  • 診斷檢查室
  • 居家醫療
  • 醫院
    • 私立醫院
    • 公立醫院

第11章：乳膠醫用手套市場：依銷售管道分類

  • 線上
  • 離線

第12章：乳膠醫用手套市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：乳膠醫用手套市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：乳膠醫用手套市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國乳膠醫用手套市場

第16章：中國乳膠醫用手套市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Ansell Limited
  • Cardinal Health Inc
  • Clean Q Grip（M）Sdn. Bhd.
  • Dynarex Corporation
  • Hartalega Holdings Berhad
  • Kimberly-Clark Corporation
  • Kossan Rubber Industries Bhd
  • Medline Industries LP
  • Semperit AG Holding
  • SHIELD Scientific BV
  • Supermax Corporation Berhad
  • Top Glove Corporation Bhd
  • UG Healthcare Corporation
  • Valutek Inc.
Product Code: MRR-2D668742FE43

The Latex Medical Gloves Market was valued at USD 14.13 billion in 2025 and is projected to grow to USD 14.93 billion in 2026, with a CAGR of 5.24%, reaching USD 20.22 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.13 billion
Estimated Year [2026] USD 14.93 billion
Forecast Year [2032] USD 20.22 billion
CAGR (%) 5.24%

A clear, contextual introduction to the latex medical gloves category that balances clinical performance priorities with supply chain and regulatory realities

Latex medical gloves occupy a critical intersection of clinical performance, supply chain complexity, and evolving regulatory expectations. This report's introduction frames the latex glove category in the context of clinical demands for tactile sensitivity and fit, juxtaposed against growing concerns about latex protein sensitization and the broad industry transition toward alternative elastomers. The narrative begins by clarifying the product family, including powder-free and powdered options, and distinguishes between use cases that prioritize dexterity, barrier integrity, or extended wear.

The introductory analysis then maps stakeholder priorities across hospital procurement teams, ambulatory care facilities, diagnostic laboratories, and home healthcare providers, explaining how procurement drivers differ by care setting. It emphasizes the distinct requirements of examination gloves versus surgical gloves, noting how surgical sub-specialties such as cardiovascular, general, and orthopedic surgery exert day-to-day and procedural performance demands that influence product selection. Finally, the introduction outlines the key forces shaping category dynamics today: patient safety and allergy mitigation, sustainability and waste management pressures, regulatory scrutiny over manufacturing practices, and the competitive interplay among manufacturers, distributors, and e-commerce platforms. These foundational observations set up the deeper, data-driven inquiries that follow, providing context for segmentation, regional dynamics, and strategic recommendations.

How clinical safety concerns, sustainability mandates, and evolving distribution channels are converging to fundamentally reshape the latex glove industry landscape

The landscape for latex medical gloves is undergoing transformative shifts driven by safety protocols, material science evolution, and structural changes in healthcare procurement. At the clinical interface, heightened awareness of latex allergies has accelerated the adoption of alternative materials in many institutions, prompting manufacturers to refine formulations and change production emphasis. Concurrently, sustainability imperatives are reshaping product design and packaging decisions, with lifecycle considerations influencing procurement choices as hospitals and health systems seek to reduce medical waste and improve environmental disclosures.

On the commercial side, distribution models are evolving. Traditional direct tenders, both government and private, continue to command significant volumes, yet e-commerce channels including manufacturer websites and third-party platforms are enabling faster replenishment cycles and expanded vendor visibility. Third-party distribution through medical distributors and pharmacy channels remains vital for last-mile delivery and catalog consolidation. These shifts are reinforced by technological adoption in sterilization, quality testing, and traceability, which together elevate supplier qualification standards. As a result, contract dynamics are changing: longer qualification timelines and enhanced compliance documentation are becoming prerequisites for supply continuity. This section synthesizes these forces to illustrate how clinical, environmental, and logistical drivers are converging to redefine competitive advantage in the latex glove market.

An analytical examination of how United States tariff changes scheduled for 2025 can cumulatively alter cost structures, sourcing strategies, and supply resilience across the latex glove value chain

Anticipated tariff adjustments announced for 2025 by the United States have the potential to exert cumulative pressure across sourcing, pricing, and inventory strategies for latex medical gloves. When tariffs are applied to imported medical supplies, the most immediate effect manifests in landed cost increases for import-dependent buyers, which in turn incentivizes procurement teams to reassess supplier portfolios and shift volumes toward domestic production or alternative sourcing jurisdictions. Over time, these cost signals catalyze structural responses: suppliers may reconfigure manufacturing footprints, invest in local or regional production, or renegotiate commercial terms to preserve market access.

Beyond direct cost implications, tariff-driven shifts influence supply chain behavior. Buyers commonly respond by increasing safety stock, diversifying supplier lists, and accelerating qualification for secondary vendors to mitigate single-source exposure. Manufacturers and distributors facing tariff-related margin compression often pursue operational efficiencies, such as higher automation levels or streamlined product SKUs, to offset input cost rises. In parallel, payers and health systems evaluate clinical equivalency among glove types; where latex alternatives meet clinical needs and regulatory requirements, substitution may reduce reliance on tariff-affected imports. The cumulative impact of tariffs is therefore multifaceted: it alters cost structures, accelerates supply chain diversification, prompts regional production investment, and strengthens the commercial case for material substitution and procurement flexibility.

In-depth segmentation insights that connect product coating, application, end-user dynamics, and distribution channels to clinical requirements and procurement behavior

Segmentation analysis reveals nuanced demand patterns that should inform product development and commercial strategies across the latex glove category. Based on product coating, clinicians and procurement officers distinguish between powder-free and powdered gloves due to differences in donning ease, particulate control, and regulatory acceptability; powder-free options are increasingly preferred in settings where contamination control and patient safety are paramount, while powdered variants retain niche utility where rapid donning is critical. Based on application type, the market is studied across examination gloves and surgical gloves, with the surgical subset further categorized into cardiovascular surgery, general surgery, and orthopedic surgery, each of which imposes distinct tactile, tensile, and sterility requirements that inform material selection and quality validation.

Based on end user, demand streams vary significantly: ambulatory care centers prioritize cost-effectiveness and supply consistency; diagnostic laboratories emphasize chemical resistance and contamination control; home healthcare requires packaging and dispensing formats conducive to non-clinical caregivers; and hospitals, which are further segmented into private and public institutions, balance performance with procurement constraints and regulatory compliance. Finally, based on distribution channel, procurement pathways include direct tender, e-commerce, and third-party distribution. Direct tender activity, encompassing both government and private tenders, remains a dominant procurement mechanism for institutional buyers, while e-commerce - via manufacturer websites and third-party platforms - accelerates replenishment and expands buyer choice. Third-party distribution, including medical distributors and pharmacy stores, continues to serve critical roles in inventory aggregation, clinical supply consulting, and last-mile logistics. Understanding the intersections among these segmentation axes is essential to align product portfolios, regulatory dossiers, and commercial approaches with buyer expectations and procedural demands.

How regional regulatory frameworks, manufacturing footprints, and procurement priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific shape product adoption and supply resilience

Regional dynamics shape both supply-side capabilities and demand-side preferences across the latex glove category, with pronounced variation between the Americas, Europe Middle East & Africa, and Asia-Pacific regions. In the Americas, clinical buyers emphasize regulatory compliance and supplier transparency alongside logistical reliability; regional manufacturing capacity and nearshoring options are increasingly evaluated to reduce exposure to import disruptions and tariff volatility. Transitioning from clinical needs to procurement realities, facilities in North and South America frequently prioritize products that combine tactile performance with demonstrable quality management systems.

In Europe Middle East & Africa, regulatory rigor and sustainability expectations are often elevated, prompting manufacturers and distributors to focus on allergen reduction strategies, product stewardship, and extended supply-chain traceability. Procurement teams in these regions also consider life-cycle impacts and waste management policies when evaluating glove options. In the Asia-Pacific region, proximity to large-scale manufacturing hubs shapes competitive dynamics, delivering cost advantages but also heightening attention to labor standards and environmental controls. Across all regions, inter-regional trade flows, logistics infrastructure, and regulatory alignment influence the pace of new product adoption and the strategic positioning of suppliers. Collectively, these regional dynamics inform decisions on production siting, compliance investments, and go-to-market prioritization.

How manufacturers, distributors, and strategic partners are differentiating through quality systems, supply agreements, and value-added services to secure long-term institutional relationships

Competitive behavior among firms operating in the latex glove category is being redefined by capability differentiation, quality assurance investments, and strategic partnerships. Leading manufacturers are investing in process controls, allergen mitigation technologies, and third-party certifications to sustain hospital and surgical relationships, while new entrants focus on niche value propositions such as biodegradable materials, bespoke sterile packaging, or rapid-response production lines that support emergency procurement. Distribution partners and medical wholesalers are expanding service portfolios to include inventory analytics, contract management support, and e-procurement integration, thereby increasing the importance of digital channels and data-driven customer engagement.

Strategic alliances between manufacturers and healthcare systems are increasingly prevalent, with long-term supply agreements conditioned on compliance milestones and volume flexibility. Contract manufacturers and private-label producers are also playing a larger role, allowing health systems and group purchasing organizations to secure branded-equivalent products under private contracts. Additionally, mergers and acquisitions remain a tool for acquiring manufacturing scale, technological capabilities, and access to new geographies, while forward-looking players emphasize ESG reporting and occupational safety as differentiators. Taken together, company strategies now encompass operational resilience, regulatory readiness, and customer-centric services as core competitive axes in the latex glove ecosystem.

Practical strategic actions manufacturers and distributors can implement now to build resilience, meet clinical demands, and create sustainable commercial differentiation

Industry leaders can take decisive actions to strengthen market positions by aligning product portfolios, supply chains, and commercial models with evolving clinical and regulatory expectations. First, manufacturers should prioritize investments in allergen reduction processes, robust quality management systems, and verifiable certifications that address hospital procurement requirements, thereby reducing friction during supplier qualification. Second, organizations should diversify manufacturing footprints and add redundancy in critical supply nodes to guard against tariff exposure and logistic disruptions, while enabling faster response to region-specific demand spikes.

Third, companies should expand digital engagement capabilities across e-commerce platforms and procurement integrations to improve order visibility, reduce lead times, and support just-in-time replenishment models. Fourth, building collaborative partnerships with distributors and health systems to co-develop packaging formats, sterile supply kits, and education for end users can strengthen customer loyalty and justify premium positioning. Fifth, embed sustainability into product design and end-of-life planning, including exploring biodegradable compounds and recyclable packaging, to meet institutional environmental targets. Finally, procurement and commercial teams should develop scenario-based contracting approaches that incorporate flexibility clauses for tariff events, quality incidents, and rapid scale-up requests. These combined actions will improve resilience, support clinical acceptance, and create commercial differentiation in a competitive and regulated landscape.

A rigorous, mixed-methods research methodology that integrates frontline clinical interviews, supply-chain mapping, and scenario analysis to validate actionable industry insights

The research methodology underpinning this report blends qualitative and quantitative techniques to generate a comprehensive view of the latex medical gloves environment. Primary interviews were conducted with clinical procurement leads, infection control specialists, distribution executives, and regulatory advisors to capture first-hand perspectives on product performance, sourcing constraints, and qualification hurdles. Secondary research drew on regulatory guidance documents, manufacturing best-practice frameworks, and publicly disclosed company reports to triangulate claims about production methods, quality systems, and distribution models.

Analytical methods included supply-chain mapping to identify critical nodes and points of vulnerability, procurement pathway analysis to compare direct tender, e-commerce, and third-party distribution impacts, and product-segmentation alignment studies that connect clinical applications to material and design attributes. Scenario analysis was used to explore the implications of tariff shifts, regulatory tightening, and substitution trends without making market size or forecasting claims. Throughout, validation steps ensured that insights reflect operational realities and are consistent with documented regulatory expectations and clinical practice. The methodology balances practitioner testimony with documentary evidence to provide actionable intelligence for decision-makers.

An integrative conclusion emphasizing the need for quality, supply resilience, and sustainability to determine long-term competitive advantage in latex gloves

In conclusion, the latex medical gloves category stands at a strategic inflection point where clinical safety considerations, supply chain resilience, and sustainability imperatives intersect. Latex continues to offer distinct tactile advantages for many clinical applications, especially in surgical specialties that demand sensitivity and fit, yet allergy concerns and the rise of alternative elastomers are reshaping procurement decisions and innovation agendas. Distribution channels and contracting mechanisms are simultaneously evolving as buyers seek greater transparency, faster replenishment, and contractual flexibility to hedge against cost and availability shocks.

To navigate this evolving landscape, stakeholders must balance near-term operational continuity with mid-term strategic investments in quality systems, regional manufacturing capabilities, and product stewardship. Procurement teams and suppliers who align their offerings with clinical requirements, regulatory expectations, and environmental commitments will be best positioned to secure long-term institutional relationships. The combination of targeted product development, diversified sourcing strategies, and collaborative commercial models will determine which organizations emerge as reliable partners to healthcare systems operating under increasingly stringent performance and sustainability standards.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Latex Medical Gloves Market, by Product Coating

  • 8.1. Powder-Free
  • 8.2. Powdered

9. Latex Medical Gloves Market, by Application Type

  • 9.1. Examination
  • 9.2. Surgical
    • 9.2.1. Cardiovascular Surgery
    • 9.2.2. General Surgery
    • 9.2.3. Orthopedic Surgery

10. Latex Medical Gloves Market, by End User

  • 10.1. Ambulatory Care Centers
  • 10.2. Diagnostic Laboratories
  • 10.3. Home Healthcare
  • 10.4. Hospitals
    • 10.4.1. Private Hospitals
    • 10.4.2. Public Hospitals

11. Latex Medical Gloves Market, by Sales Channel

  • 11.1. Online
  • 11.2. Offline

12. Latex Medical Gloves Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Latex Medical Gloves Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Latex Medical Gloves Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Latex Medical Gloves Market

16. China Latex Medical Gloves Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Ansell Limited
  • 17.6. Cardinal Health Inc
  • 17.7. Clean Q Grip (M) Sdn. Bhd.
  • 17.8. Dynarex Corporation
  • 17.9. Hartalega Holdings Berhad
  • 17.10. Kimberly-Clark Corporation
  • 17.11. Kossan Rubber Industries Bhd
  • 17.12. Medline Industries LP
  • 17.13. Semperit AG Holding
  • 17.14. SHIELD Scientific B.V.
  • 17.15. Supermax Corporation Berhad
  • 17.16. Top Glove Corporation Bhd
  • 17.17. UG Healthcare Corporation
  • 17.18. Valutek Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LATEX MEDICAL GLOVES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LATEX MEDICAL GLOVES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES LATEX MEDICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA LATEX MEDICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY POWDER-FREE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY POWDER-FREE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY POWDER-FREE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY POWDERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY POWDERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY POWDERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY EXAMINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY EXAMINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY EXAMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS LATEX MEDICAL GLOVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. GCC LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GCC LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 120. GCC LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. GCC LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 122. GCC LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. GCC LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 124. GCC LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. G7 LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. G7 LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 141. G7 LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. G7 LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 143. G7 LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. G7 LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 145. G7 LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. NATO LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. NATO LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 148. NATO LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. NATO LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 150. NATO LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. NATO LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. NATO LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES LATEX MEDICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA LATEX MEDICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)